GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution

Cell Reports

Volumn 13, Issue 2, 2015, Pages 365-375

  Karaca, Melis ^a   Frigerio, Francesca ^a   Migrenne, Stephanie ^b   Martin Levilain, Juliette ^a   Skytt, Dorte M ^c   Pajecka, Kamilla ^c   Martin del Rio, Rafael ^d   Gruetter, Rolf ^e   Tamarit Rodriguez, Jorge ^d   Waagepetersen, Helle S ^c   Magnan, Christophe ^b   Maechler, Pierre ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b CNRS   (France)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; PROTEIN GLUD1; UNCLASSIFIED DRUG; GLUCOSE; GLUD1 PROTEIN, MOUSE; GLUTAMATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTONOMIC NERVOUS SYSTEM; BRAIN METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; ENERGY TRANSFER; ENZYME METABOLISM; GLUCONEOGENESIS; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYMPATHETIC TONE; ANIMAL; CELL CULTURE; CYTOLOGY; GENETICS; LIVER; METABOLISM; OXIDATION REDUCTION REACTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ASTROCYTES; CELLS, CULTURED; ENERGY METABOLISM; GLUCOSE; GLUTAMIC ACID; HYPOTHALAMUS; LIVER; MALE; MICE; OXIDATION-REDUCTION; RECEPTORS, GLUTAMATE;

EID: 84944028366     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.09.003     Document Type: Article

References (62)

1. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., Carling D., Small C.J. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 2004, 279:12005-12008.
2. Bak L.K., Schousboe A., Waagepetersen H.S. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J. Neurochem. 2006, 98:641-653.
3. Baudry M., Lynch G. Regulation of glutamate receptors by cations. Nature 1979, 282:748-750.
4. Berthoud H.R., Fox E.A., Powley T.L. Localization of vagal preganglionics that stimulate insulin and glucagon secretion. Am. J. Physiol. 1990, 258:R160-R168.
5. Blouet C., Schwartz G.J. Hypothalamic nutrient sensing in the control of energy homeostasis. Behav. Brain Res. 2010, 209:1-12.
6. Brodie B.B., Costa E., Dlabac A., Neff N.H., Smookler H.H. Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J. Pharmacol. Exp. Ther. 1966, 154:493-498.
7. Choi I.Y., Lee S.P., Kim S.G., Gruetter R. In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia. J. Cereb. Blood Flow Metab. 2001, 21:653-663.
8. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
9. Escartin C., Valette J., Lebon V., Bonvento G. Neuron-astrocyte interactions in the regulation of brain energy metabolism: a focus on NMR spectroscopy. J. Neurochem. 2006, 99:393-401.
10. Frigerio F., Karaca M., De Roo M., Mlynárik V., Skytt D.M., Carobbio S., Pajecka K., Waagepetersen H.S., Gruetter R., Muller D., Maechler P. Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission. J. Neurochem. 2012, 123:342-348.
11. Gaisler-Salomon I., Miller G.M., Chuhma N., Lee S., Zhang H., Ghoddoussi F., Lewandowski N., Fairhurst S., Wang Y., Conjard-Duplany A., et al. Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. Neuropsychopharmacology 2009, 34:2305-2322.
12. German J., Kim F., Schwartz G.J., Havel P.J., Rhodes C.J., Schwartz M.W., Morton G.J. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 2009, 150:4502-4511.
13. Gordon J.A. Testing the glutamate hypothesis of schizophrenia. Nat. Neurosci. 2010, 13:2-4.
14. Gruetter R., Novotny E.J., Boulware S.D., Mason G.F., Rothman D.L., Shulman G.I., Prichard J.W., Shulman R.G. Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose. J. Neurochem. 1994, 63:1377-1385.
15. Hardie D.G., Carling D. The AMP-activated protein kinase--fuel gauge of the mammalian cell?. Eur. J. Biochem. 1997, 246:259-273.
16. Harris L.W., Lockstone H.E., Khaitovich P., Weickert C.S., Webster M.J., Bahn S. Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. BMC Med. Genomics 2009, 2:28.
17. Hertz L., Peng L., Dienel G.A. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J. Cereb. Blood Flow Metab. 2007, 27:219-249.
18. Hucho F., Rasched I., Sund H. Studies of glutamate dehydrogenase: analysis of functional areas and functional groups. Eur. J. Biochem. 1975, 52:221-230.
19. Ikegami M., Ikeda H., Ohashi T., Ohsawa M., Ishikawa Y., Kai M., Kamei A., Kamei J. Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5'-monophosphate-activated protein kinase. Diabetes Obes. Metab. 2013, 15:1128-1135.
20. Karaca M., Maechler P. Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter. Neurochem. Res. 2014, 39:456-459.
21. Karaca M., Frigerio F., Maechler P. From pancreatic islets to central nervous system, the importance of glutamate dehydrogenase for the control of energy homeostasis. Neurochem. Int. 2011, 59:510-517.
22. Karnani M., Burdakov D. Multiple hypothalamic circuits sense and regulate glucose levels. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R47-R55.
23. Kety S.S. The general metabolism of the brain in vivo. Metabolism of the Nervous System 1957, 221-237. Pergamon. D. Richter (Ed.).
24. Kim E.K., Miller I., Aja S., Landree L.E., Pinn M., McFadden J., Kuhajda F.P., Moran T.H., Ronnett G.V. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J. Biol. Chem. 2004, 279:19970-19976.
25. Kim M.S., Park J.Y., Namkoong C., Jang P.G., Ryu J.W., Song H.S., Yun J.Y., Namgoong I.S., Ha J., Park I.S., et al. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med. 2004, 10:727-733.
26. Lam C.K., Chari M., Lam T.K. CNS regulation of glucose homeostasis. Physiology (Bethesda) 2009, 24:159-170.
27. Lam C.K., Chari M., Su B.B., Cheung G.W., Kokorovic A., Yang C.S., Wang P.Y., Lai T.Y., Lam T.K. Activation of N-methyl-D-aspartate (NMDA) receptors in the dorsal vagal complex lowers glucose production. J. Biol. Chem. 2010, 285:21913-21921.
28. Lee K., Li B., Xi X., Suh Y., Martin R.J. Role of neuronal energy status in the regulation of adenosine 5'-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. Endocrinology 2005, 146:3-10.
29. Lovatt D., Sonnewald U., Waagepetersen H.S., Schousboe A., He W., Lin J.H., Han X., Takano T., Wang S., Sim F.J., et al. The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J. Neurosci. 2007, 27:12255-12266.
30. Magistretti P.J., Pellerin L., Rothman D.L., Shulman R.G. Energy on demand. Science 1999, 283:496-497.
31. Mason G.F., Gruetter R., Rothman D.L., Behar K.L., Shulman R.G., Novotny E.J. Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J. Cereb. Blood Flow Metab. 1995, 15:12-25.
32. Mastorodemos V., Zaganas I., Spanaki C., Bessa M., Plaitakis A. Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. J. Neurosci. Res. 2005, 79:65-73.
33. Matsuhisa M., Yamasaki Y., Shiba Y., Nakahara I., Kuroda A., Tomita T., Iida M., Ikeda M., Kajimoto Y., Kubota M., Hori M. Important role of the hepatic vagus nerve in glucose uptake and production by the liver. Metabolism 2000, 49:11-16.
34. McCrimmon R.J., Fan X., Ding Y., Zhu W., Jacob R.J., Sherwin R.S. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes 2004, 53:1953-1958.
35. McCrimmon R.J., Shaw M., Fan X., Cheng H., Ding Y., Vella M.C., Zhou L., McNay E.C., Sherwin R.S. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia. Diabetes 2008, 57:444-450.
36. McKenna M.C. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J. Neurosci. Res. 2007, 85:3347-3358.
37. McKenna M.C. Substrate competition studies demonstrate oxidative metabolism of glucose, glutamate, glutamine, lactate and 3-hydroxybutyrate in cortical astrocytes from rat brain. Neurochem. Res. 2012, 37:2613-2626.
38. McKenna M.C. Glutamate pays its own way in astrocytes. Front. Endocrinol. (Lausanne) 2013, 4:191.
39. McKenna M.C., Sonnewald U., Huang X., Stevenson J., Zielke H.R. Exogenous glutamate concentration regulates the metabolic fate of glutamate in astrocytes. J. Neurochem. 1996, 66:386-393.
40. Meldrum B.S. The role of glutamate in epilepsy and other CNS disorders. Neurology 1994, 44(11, Suppl 8):S14-S23.
41. Michaelidis T.M., Tzimagiorgis G., Moschonas N.K., Papamatheakis J. The human glutamate dehydrogenase gene family: gene organization and structural characterization. Genomics 1993, 16:150-160.
42. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferré P., Birnbaum M.J., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
43. Nehlig A. Brain uptake and metabolism of ketone bodies in animal models. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70:265-275.
44. Patel D.G. Role of parasympathetic nervous system in glucagon response to insulin-induced hypoglycemia in normal and diabetic rats. Metabolism 1984, 33:1123-1127.
45. Peters A., Schweiger U., Pellerin L., Hubold C., Oltmanns K.M., Conrad M., Schultes B., Born J., Fehm H.L. The selfish brain: competition for energy resources. Neurosci. Biobehav. Rev. 2004, 28:143-180.
46. Rolfe D.F., Brown G.C. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol. Rev. 1997, 77:731-758.
47. Sanner T. Formation of transient complexes in the glutamate dehydrogenase catalyzed reaction. Biochemistry 1975, 14:5094-5098.
48. Shimazu T. Regulation of glycogen metabolism in liver by the autonomic nervous system. V. Activation of glycogen synthetase by vagal stimulation. Biochim. Biophys. Acta 1971, 252:28-38.
49. Shimazu T. Neuronal regulation of hepatic glucose metabolism in mammals. Diabetes Metab. Rev. 1987, 3:185-206.
50. Sokoloff L. Metabolism of the central nervous system in vivo. Handbook of Physiology: Neurophysiology 1960, 1843-1864. American Physiological Society. J. Field, H.W. Magoun, V.E. Hall (Eds.).
51. Stoppa G.R., Cesquini M., Roman E.A., Prada P.O., Torsoni A.S., Romanatto T., Saad M.J., Velloso L.A., Torsoni M.A. Intracerebroventricular injection of citrate inhibits hypothalamic AMPK and modulates feeding behavior and peripheral insulin signaling. J. Endocrinol. 2008, 198:157-168.
52. Taborsky G.J., Mundinger T.O. Minireview: The role of the autonomic nervous system in mediating the glucagon response to hypoglycemia. Endocrinology 2012, 153:1055-1062.
53. Tanida M., Yamamoto N. Central AMP-activated protein kinase affects sympathetic nerve activity in rats. Neurosci. Lett. 2011, 503:167-170.
54. Vannucci S.J., Maher F., Simpson I.A. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 1997, 21:2-21.
55. Verleysdonk S., Hamprecht B. Synthesis and release of L-serine by rat astroglia-rich primary cultures. Glia 2000, 30:19-26.
56. Westergaard N., Drejer J., Schousboe A., Sonnewald U. Evaluation of the importance of transamination versus deamination in astrocytic metabolism of [U-13C]glutamate. Glia 1996, 17:160-168.
57. Yang X.J., Kow L.M., Pfaff D.W., Mobbs C.V. Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes 2004, 53:67-73.
58. Yang C.S., Lam C.K., Chari M., Cheung G.W., Kokorovic A., Gao S., Leclerc I., Rutter G.A., Lam T.K. Hypothalamic AMP-activated protein kinase regulates glucose production. Diabetes 2010, 59:2435-2443.
59. Yu A.C., Schousboe A., Hertz L. Metabolic fate of 14C-labeled glutamate in astrocytes in primary cultures. J. Neurochem. 1982, 39:954-960.
60. Zaganas I., Waagepetersen H.S., Georgopoulos P., Sonnewald U., Plaitakis A., Schousboe A. Differential expression of glutamate dehydrogenase in cultured neurons and astrocytes from mouse cerebellum and cerebral cortex. J. Neurosci. Res. 2001, 66:909-913.
61. Zaganas I., Spanaki C., Plaitakis A. Expression of human GLUD2 glutamate dehydrogenase in human tissues: functional implications. Neurochem. Int. 2012, 61:455-462.
62. Zielke H.R., Zielke C.L., Baab P.J. Direct measurement of oxidative metabolism in the living brain by microdialysis: a review. J. Neurochem. 2009, 109(Suppl 1):24-29.